These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19725034)

  • 1. CTEN/tensin 4 expression induces sensitivity to paclitaxel in prostate cancer.
    Li Y; Mizokami A; Izumi K; Narimoto K; Shima T; Zhang J; Dai J; Keller ET; Namiki M
    Prostate; 2010 Jan; 70(1):48-60. PubMed ID: 19725034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skp2 is associated with paclitaxel resistance in prostate cancer cells.
    Yang Y; Lu Y; Wang L; Mizokami A; Keller ET; Zhang J; Fu J
    Oncol Rep; 2016 Jul; 36(1):559-66. PubMed ID: 27175797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines.
    Takeda M; Mizokami A; Mamiya K; Li YQ; Zhang J; Keller ET; Namiki M
    Prostate; 2007 Jun; 67(9):955-67. PubMed ID: 17440963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
    Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cten, a COOH-terminal tensin-like protein with prostate restricted expression, is down-regulated in prostate cancer.
    Lo SH; Lo TB
    Cancer Res; 2002 Aug; 62(15):4217-21. PubMed ID: 12154022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1.
    Li X; Han X; Wei P; Yang J; Sun J
    Cancer Biol Ther; 2020 May; 21(5):452-462. PubMed ID: 32089062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of cytokeratin 18 is associated with paclitaxel‑resistance and tumor aggressiveness in prostate cancer.
    Yin B; Zhang M; Zeng Y; Li Y; Zhang C; Getzenberg RH; Song Y
    Int J Oncol; 2016 Apr; 48(4):1730-6. PubMed ID: 26892177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ΔNp63α Transcriptionally Regulates the Expression of CTEN That Is Associated with Prostate Cell Adhesion.
    Yang K; Wu WM; Chen YC; Lo SH; Liao YC
    PLoS One; 2016; 11(1):e0147542. PubMed ID: 26784942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-terminal tensin-like protein mediates invasion of human lung cancer cells and is regulated by signal transducer and activator of transcription 3.
    Bennett DT; Reece TB; Foley LS; Sjoberg A; Meng X; Fullerton DA; Weyant MJ
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):369-75. PubMed ID: 25439778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines.
    Machioka K; Izumi K; Kadono Y; Iwamoto H; Naito R; Makino T; Kadomoto S; Natsagdorj A; Keller ET; Zhang J; Mizokami A
    Oncotarget; 2018 Mar; 9(22):16185-16196. PubMed ID: 29662635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cells.
    Natsagdorj A; Izumi K; Hiratsuka K; Machioka K; Iwamoto H; Naito R; Makino T; Kadomoto S; Shigehara K; Kadono Y; Lin WJ; Maolake A; Mizokami A
    Cancer Sci; 2019 Jan; 110(1):279-288. PubMed ID: 30426599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A reciprocal tensin-3-cten switch mediates EGF-driven mammary cell migration.
    Katz M; Amit I; Citri A; Shay T; Carvalho S; Lavi S; Milanezi F; Lyass L; Amariglio N; Jacob-Hirsch J; Ben-Chetrit N; Tarcic G; Lindzen M; Avraham R; Liao YC; Trusk P; Lyass A; Rechavi G; Spector NL; Lo SH; Schmitt F; Bacus SS; Yarden Y
    Nat Cell Biol; 2007 Aug; 9(8):961-9. PubMed ID: 17643115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple pathways regulate Cten in colorectal cancer without a Tensin switch.
    Thorpe H; Akhlaq M; Jackson D; Al Ghamdi S; Storr S; Martin S; Ilyas M
    Int J Exp Pathol; 2015 Dec; 96(6):362-9. PubMed ID: 26852686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-terminal tensin-like gene functions as an oncogene and promotes cell motility in pancreatic cancer.
    Al-Ghamdi S; Cachat J; Albasri A; Ahmed M; Jackson D; Zaitoun A; Guppy N; Otto WR; Alison MR; Kindle KB; Ilyas M
    Pancreas; 2013 Jan; 42(1):135-40. PubMed ID: 22750970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CCL2-CCR2 Axis Contributes to Migration of Cabazitaxel-resistant Prostate Cancer Cells.
    Natsagdorj A; Izumi K; Hiratsuka K; Naito R; Kadomoto S; Iwamoto H; Yaegashi H; Shigehara K; Nakata H; Mizokami A
    Anticancer Res; 2023 Jun; 43(6):2561-2569. PubMed ID: 37247914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-terminal Tensin-like (CTEN) is an oncogene which alters cell motility possibly through repression of E-cadherin in colorectal cancer.
    Albasri A; Seth R; Jackson D; Benhasouna A; Crook S; Nateri AS; Chapman R; Ilyas M
    J Pathol; 2009 May; 218(1):57-65. PubMed ID: 19214987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative transcriptomics-based identification of cryptic drivers of taxol-resistance genes in ovarian carcinoma cells: Analysis of the androgen receptor.
    Sun NK; Huang SL; Lu HP; Chang TC; Chao CC
    Oncotarget; 2015 Sep; 6(29):27065-82. PubMed ID: 26318424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoresistance in prostate cancer cells is regulated by miRNAs and Hedgehog pathway.
    Singh S; Chitkara D; Mehrazin R; Behrman SW; Wake RW; Mahato RI
    PLoS One; 2012; 7(6):e40021. PubMed ID: 22768203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel selenonucleoside suppresses tumor growth by targeting Skp2 degradation in paclitaxel-resistant prostate cancer.
    Byun WS; Jin M; Yu J; Kim WK; Song J; Chung HJ; Jeong LS; Lee SK
    Biochem Pharmacol; 2018 Dec; 158():84-94. PubMed ID: 30292755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Wnt signaling downregulates Akt activity and induces chemosensitivity in PTEN-mutated prostate cancer cells.
    Ohigashi T; Mizuno R; Nakashima J; Marumo K; Murai M
    Prostate; 2005 Jan; 62(1):61-8. PubMed ID: 15389810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.